top of page
Parkinson's Disease Medical Research Study: Cohort #3
September 8-14, 2022
Zhittya Genesis Medicine's third study into the use of intranasally delivered FGF-1 to possible treat Parkinson's Disease in human patients in the British Virgin Islands
bottom of page